A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a ...

For decades, one of the greatest challenges to treating neurological disorders like attention-deficit/hyperactivity disorder ...

Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and ...

Hyperarousal plays an important role in mental disorders. It influences the severity of insomnia, depression, anxiety, ...

Leading Australian psychiatrists say the findings should serve as a wake-up call for the government to better regulate the $1 billion medicinal cannabis industry.

Although they’re different mental health conditions, they commonly co-occur and have some symptoms that overlap. Here’s why that’s important when it comes to getting the right treatment. Depression ...

It’s already known that adolescents who have been diagnosed with attention deficit hyperactivity disorder, or ADHD — affecting about 11.4% of U.S. children 3-14 — are at a higher risk of anxiety and ...

A new nationwide study reveals that misophonia rarely occurs in isolation. Approximately 65% of individuals with severe sound ...

A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe ...

Anxiety disorders are complex mental health conditions characterised by an enduring sensitivity to threat and a propensity to process negative information in an exaggerated manner. A central feature ...

If you have anxiety, know that you are not alone. Anxiety disorders are the most common form of mental illness in the United States. Anxiety disorders include, but are not limited to, post traumatic ...